Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials. | JCO Precis Oncol;7: e2200573, 2023 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials.

Karasic, Thomas B; Eads, Jennifer R; Goyal, Lipika.

Affiliation

Karasic TB; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA.
Eads JR; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA.
Goyal L; Department of Medicine, Division of Hematology and Oncology, Stanford Cancer Center, Palo Alto, CA.

JCO Precis Oncol ; 7: e2200573, 2023 04.

Article in En | MEDLINE | ID: mdl-37053534

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: